BSX vs. GEHC: Boston Scientific vs. GE HealthCare Stock Comparison

Company Profile

Boston Scientific (BSX) and GE HealthCare (GEHC) are both classified in the Health Care Equipment sub-industry within the broader Health Care Equipment & Supplies industry, placing them in the closest GICS peer bucket.

Boston Scientific (BSX) has more than two decades of public-market history since May 19, 1992, whereas GE HealthCare (GEHC) listed on December 15, 2022 and has a much shorter record to draw on.

Price Performance

Cumulative Growth

Trailing Returns

Calendar-Year Returns

Performance Metrics

Risk Profile

Drawdown History

Return Distribution

Risk Metrics

Risk-Adjusted Performance

Risk-Return Positioning

Risk-Adjusted Metrics

Profitability

GE HealthCare (GEHC) at 20.01% sits in the top ROE quartile, while Boston Scientific (BSX) at 14.12% is closer to the peer norm — stronger capital efficiency for GEHC.

For every dollar of sales, both Boston Scientific (BSX) at 16.62% and GE HealthCare (GEHC) at 9.95% retain more as net profit than most peers, landing in the top net margin quartile of their industries.

Both Boston Scientific (BSX) at 19.05% and GE HealthCare (GEHC) at 15.33% convert sales into operating profit at a top-quartile rate, pointing to tighter cost discipline before financing and tax.

Profitability Metrics

Growth

Both Boston Scientific (BSX) at 19.87% and GE HealthCare (GEHC) at 4.84% land near their industries' usual revenue growth ranges, so top-line momentum looks broadly in line with peers on both sides.

Boston Scientific (BSX) at 55.20% sits in the top EPS growth quartile, while GE HealthCare (GEHC) at 4.84% is closer to the peer norm — faster per-share earnings growth for BSX.

Growth Metrics

Financial Strength

Both Boston Scientific (BSX) at 1.37 and GE HealthCare (GEHC) at 1.30 run current ratio in the tighter-liquidity quartile of industry peers, leaving thinner cushions against current liabilities than typical competitors.

Both Boston Scientific (BSX) at 0.46 and GE HealthCare (GEHC) at 0.88 fund their balance sheets with roughly industry-typical debt-to-equity mixes.

Financial Strength Metrics

Dividends

Boston Scientific (BSX) pays no dividend (yield 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile GE HealthCare (GEHC) reports a yield of 0.17%, ranking against industry peers normally.

Boston Scientific (BSX) pays no dividend (payout 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile GE HealthCare (GEHC) reports a payout of 2.96%, ranking against industry peers normally.

Dividend Metrics

Valuation

Both Boston Scientific (BSX) at 18.04 and GE HealthCare (GEHC) at 17.42 sit in the cheaper earnings-multiple quartile for P/E ratio, with the market paying less for a dollar of trailing earnings than it pays for typical peers.

On P/S ratio, both Boston Scientific (BSX) at 2.94 and GE HealthCare (GEHC) at 1.72 are priced roughly in line with their industries — neither looks cheap nor rich on a sales basis.

On P/B ratio, both Boston Scientific (BSX) at 2.42 and GE HealthCare (GEHC) at 3.21 are valued close to their industries’ norm against book — neither stands out from peers.

Valuation Metrics